Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00877513 · ClinicalTrials.gov registry record · NA
Insulin Resistance in Smokers Undergoing Smoking Cessation
A NA study, sponsored by Charles Drew University of Medicine and Science.
- Terminated
- Registry status
- NA
- Development phase
- 103
- Enrollment target
NCT00877513 is a NA study that was terminated before completion, run by Charles Drew University of Medicine and Science. The registered enrollment target is 103 participants.
The verdict
NCT00877513, a NA study, was terminated before completion, sponsored by Charles Drew University of Medicine and Science.
- TERMINATED
- Registry status
- NA
- Development phase
- 103 participants
- Enrollment target
Study Summary
Cigarette smoking increases CVD risk and worsens insulin resistance, but also contributes to weight loss; smoking cessation reduces CVD risk and improves insulin sensitivity, but also contributes to weight gain. The mechanisms that underlie these metabolic changes of cigarette smoking and smoking cessation on insulin resistance, body composition, and fat distribution are poorly understood.
Interventions
- BEHAVIORAL Smoking cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00877513
The ClinicalTrials.gov registry entry for NCT00877513 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 103 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Charles Drew University of Medicine and Science, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking cessation is the first listed.
NCT00877513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00877513 about?
NCT00877513 is a clinical study titled "Insulin Resistance in Smokers Undergoing Smoking Cessation". Cigarette smoking increases CVD risk and worsens insulin resistance, but also contributes to weight loss; smoking cessation reduces CVD risk and improves insulin sensitivity, but also contributes to weight gain. The mechanisms that underlie these metabolic changes of cigarette smoking and smoking ce...
What is the current status of trial NCT00877513?
This trial is currently terminated. It is a NA study. The enrollment target is 103 participants. The study started on 2009-02. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00877513?
The interventions under investigation include: Smoking cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00877513?
This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.